Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Germline mutations of the MSR1 gene in prostate cancer families from Germany.

Maier C, Vesovic Z, Bachmann N, Herkommer K, Braun AK, Surowy HM, Assum G, Paiss T, Vogel W.

Hum Mutat. 2006 Jan;27(1):98-102.

PMID:
16287155
2.

Germ-line alterations in MSR1 gene and prostate cancer risk.

Seppälä EH, Ikonen T, Autio V, Rökman A, Mononen N, Matikainen MP, Tammela TL, Schleutker J.

Clin Cancer Res. 2003 Nov 1;9(14):5252-6.

3.

Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.

Lindmark F, Jonsson BA, Bergh A, Stattin P, Zheng SL, Meyers DA, Xu J, Grönberg H.

Prostate. 2004 May 1;59(2):132-40.

PMID:
15042613
4.

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.

Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, Johnson JR, Suzuki H, Bujnovszky P, Wiley KE, DeMarzo AM, Bova GS, Chang B, Hall MC, McCullough DL, Partin AW, Kassabian VS, Carpten JD, Bailey-Wilson JE, Trent JM, Ohar J, Bleecker ER, Walsh PC, Isaacs WB, Meyers DA.

Nat Genet. 2002 Oct;32(2):321-5. Epub 2002 Sep 16.

PMID:
12244320
5.

No association of germline alteration of MSR1 with prostate cancer risk.

Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN.

Nat Genet. 2003 Oct;35(2):128-9. Epub 2003 Sep 7.

PMID:
12958598
6.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

7.

Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk.

Sun J, Hsu FC, Turner AR, Zheng SL, Chang BL, Liu W, Isaacs WB, Xu J.

Prostate. 2006 May 15;66(7):728-37.

PMID:
16425212
8.

Role of HPC2/ELAC2 in hereditary prostate cancer.

Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN.

Cancer Res. 2001 Sep 1;61(17):6494-9.

9.

Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23.

Wiklund F, Jonsson BA, Göransson I, Bergh A, Grönberg H.

Hum Genet. 2003 Apr;112(4):414-8. Epub 2003 Feb 20.

PMID:
12594535
10.

Germline ATBF1 mutations and prostate cancer risk.

Xu J, Sauvageot J, Ewing CM, Sun J, Liu W, Isaacs SD, Wiley KE, Diaz L, Zheng SL, Walsh PC, Isaacs WB.

Prostate. 2006 Jul 1;66(10):1082-5.

PMID:
16637072
11.

MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.

Hsing AW, Sakoda LC, Chen J, Chokkalingam AP, Sesterhenn I, Gao YT, Xu J, Zheng SL.

Carcinogenesis. 2007 Dec;28(12):2530-6. Epub 2007 Sep 3.

PMID:
17768178
12.

Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.

Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Möslein G, Schulmann K, Propping P, Friedl W.

Hum Mutat. 2004 Nov;24(5):370-80.

PMID:
15459959
13.

Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.

Nupponen NN, Wallén MJ, Ponciano D, Robbins CM, Tammela TL, Vessella RL, Carpten JD, Visakorpi T.

Genes Chromosomes Cancer. 2004 Feb;39(2):119-25.

PMID:
14695991
14.

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.

15.

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.

Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Muir K, Houlston RS, Engert JC, Roquis D, Sinnett D, Simard J, Heimdal K, Møller P, Maehle L, Badzioch M, Eeles RA, Easton DF, English DR, Southey MC, Hopper JL, Foulkes WD, Giles GG; Cancer Research UK/British Association of Urological Surgeons' Section of Oncology Collaborators..

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):397-402.

16.

A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer.

Maier C, Rösch K, Herkommer K, Bochum S, Cancel-Tassin G, Cussenot O, Häussler J, Assum G, Vogel W, Paiss T.

Eur Urol. 2002 Sep;42(3):301-7.

PMID:
12234517
17.

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.

Chang BL, Zheng SL, Isaacs SD, Wiley KE, Turner A, Li G, Walsh PC, Meyers DA, Isaacs WB, Xu J.

Cancer Res. 2004 Mar 15;64(6):1997-9.

18.

[Study on the germline mutation of MSH6 gene in Chinese hereditary nonpolyposis colorectal cancer pedigrees using PCR based sequencing].

Yan SY, Zhou XY, Cai SJ, Yu BH, Zhang TM, Li XM, Lu YM, Zhou HH, Mo SJ, Du X, Shi DR.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):640-5. Chinese.

PMID:
18067074
19.

Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.

Miller DC, Zheng SL, Dunn RL, Sarma AV, Montie JE, Lange EM, Meyers DA, Xu J, Cooney KA.

Cancer Res. 2003 Jul 1;63(13):3486-9.

20.

Clinical and genetic studies of Birt-Hogg-Dubé syndrome.

Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Lévy R, Ferlicot S, Wolkenstein P, Hammel P, Bergerheim U, Hedblad MA, Bradley M, Teh BT, Nordenskjöld M, Richard S.

J Med Genet. 2002 Dec;39(12):906-12. Erratum in: J Med Genet. 2003 Feb;40(2):150..

Supplemental Content

Support Center